A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)

Completed · Phase 2 · Has a placebo group

Conditions studied: Infection

In brief

The purpose of this study is to investigate the feasibility, safety and efficacy of oral probiotic, Lactobacillus rhamnosus versus oral placebo for reducing colonization by MRSA.

Key facts

Study ID

NCT01112995

Run by

University of Wisconsin, Madison

People needed

49

Starts

2010-01-01

Expected to finish

2012-03-01

Last updated by the study team

2015-10-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subjects will be male or female
• 18 years of age or older
• may or may not be hospitalized
• able to take oral medications
• have been found to be colonized with MRSA or at high risk of being colonized by MRSA and are not taking antibiotics

You may not qualify if…

• people on antibiotics will not be eligible to participate

Where it is running

• University of Wisconsin Hospital — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.